They showed that VAT associated with an adverse metabolic, dyslipidemic, and atherogenic obesity phenotype, whereas SAT associated with a more benign phenotype, characterized by modest associations with inflammatory biomarkers and leptin, but no independent association with dyslipidemia, insulin resistance, or atherosclerosis in individuals with obesity. The gene discussed is LEP; the disease is atherosclerosis.